The goal of this clinical trial is to learn if there is an effect of Virtual Reality (VR) based-relaxation on electroconvulsive therapy (ECT)-related anxiety. The main questions it aims to answer are:
* Does VR based-relaxation have an effect on anxiety in patients receiving ECT as part of routine clinical care?
* Does VR based-relaxation have an effect on stress symptoms and heart rate in patients receiving ECT as part of routine clinical care?
* Does depression severity have an effect on the effectivity of VR-based relaxation
Researchers will compare VR-relaxation to relaxation breathing exercises and no relaxation to see if VR-based relaxation has an effect on ECT-related anxiety.
Who can participate
Inclusion Criteria:
* Age 18-75 years
* Being treated with ECT, having had at least two sessions at study start
* Able to understand study procedure and sign informed consent
* Speaking Dutch or French
* DSM-5 diagnosis of a depressive disorder, for which ECT treatment has been initiated
Exclusion Criteria:
\- Contra-indications for VR: photosensitive epilepsy, severe travel sickness, vertigo, open wounds on the face